Usage and attitude of medical students towards mobile medical applications during and after COVID-19 lockdown: repeated cross-sectional study.

Publication date: Mar 04, 2024

COVID-19 pandemic has accelerated the shift toward e-learning, particularly in medical education. Mobile medical applications (apps) have become integral tools for e-learning due to the prevalence of smartphones among medical students. Therefore, we aim to assess the usage and attitude of undergraduate Egyptian medical students towards mobile medical apps during and after the COVID-19 lockdown. This is a two-phase repeated cross-sectional study using an online, pilot-tested, and self-administered survey conducted at the Faculty of Medicine, Menoufia University, Egypt. Phase 1 was during the academic year 2019-2020 (during lockdown), and phase 2 was during the academic year 2021-2022 (after lockdown). Out of the 4800-target population for each phase, a sample size of 140 medical students was randomly selected from each study year, resulting in a total sample size of 840 students for all six academic and clinical years for each phase. A total of 566 students in phase 1 and 616 students in phase 2 responded to the survey, with response rates of 67. 62% and 73. 33%, respectively. In phase 1, 55. 7% of students reported using medical apps, with no significant difference between males and females (60. 1% vs. 53. 8%; p = 0. 17) or between academic and clinical years (56. 3% vs. 54. 7%; p = 0. 7). In phase 2, the percentage increased to 70. 9%, with a significant difference between males and females (80% vs. 62. 9%; p 

Open Access PDF

Concepts Keywords
Academic COVID-19’ lockdown
Pandemic Medical applications
Pilot Medical education
Smartphones Medical students
Mobile apps


Type Source Name
disease MESH COVID-19
disease VO population
pathway REACTOME Reproduction
disease VO effective
disease IDO process
disease VO time
drug DRUGBANK Hexocyclium
disease VO USA
drug DRUGBANK Methyltestosterone
disease VO volume
disease VO monthly
drug DRUGBANK Coenzyme M
disease VO Gap
drug DRUGBANK Trihexyphenidyl
drug DRUGBANK Nevirapine
disease VO protocol
disease MESH aids

Original Article

(Visited 1 times, 1 visits today)